{"member_organisations": "", "identification_number": "963595828688-36", "fields_of_interest": "Public Health", "head_office_address": "Vesterbro Torv 1-3, 5.", "full_time_equivalent_fte": "3", "person_with_legal_responsibility": "Ole Schou", "industry_forums": "DANSK ERHVERV    T. +45 3374 6000 \nCONFEDERATION OF DANISH ENTERPRISE     \nSQUARE DE MEE\u00dbS 22B     \nB-1050 BRUXELLES     \nWWW.DANSKERHVERV.DK \nINFO@DANSKERHVERV.DK", "grants": "", "country_code": "dk", "inter_groups": "", "eu_initiatives": "Udkast til bekendtg\u00f8relse om kvalitet og sikkerhed ved h\u00e5ndtering af humane v\u00e6v og celler af 06-07-2018.  \n \nOverv\u00e5gning af omfanget af Brexits indvirkning p\u00e5 den for Cryos relevante lovgivning. \n \nOverv\u00e5gning af den igangv\u00e6rende evalueringen af v\u00e6vsdirektivet (DIR 2004/23/EC).  \n \nOverv\u00e5gning af udviklingen indenfor relevant national lovgivning omkring k\u00f8nscelledonation / anvendelse af k\u00f8nsceller i mennesker.", "level_of_interest": "global", "organisation_name": "Cryos International - Denmark (Cryos)", "belgium_office_post_code": "", "number_of_persons_involved": "11", "person_in_charge_of_eu_relations": "Ole Schou", "section": "II - In-house lobbyists and trade/business/professional associations", "lon": "10.1995703", "source": "", "subsection": "Companies & groups", "belgium_office_phone": "", "overall_budget_turnover_as_a_range": "", "belgium_office_address": "", "persons_accredited_for_access_to_european_parliament_premises": "", "registration_date": "17/10/2017", "estimate_of_costs_absolute_amount": "", "website_address": "http://dk.cryosinternational.com/", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "Aarhus C.", "membership": "DANSK ERHVERV    T. +45 3374 6000 \nCONFEDERATION OF DANISH ENTERPRISE     \nSQUARE DE MEE\u00dbS 22B     \nB-1050 BRUXELLES     \nWWW.DANSKERHVERV.DK \nINFO@DANSKERHVERV.DK", "head_office_post_code": "8000", "position": "Founder", "financial_year_start_date": "01/05/2017", "head_office_country": "Denmark", "number_of_ep_accredited_persons": "", "relevant_communication": "M\u00f8de med EU-kommissionen: https://ec.europa.eu/health/sites/health/files/blood_tissues_organs/docs/ev_20171026_sr_en.pdf \n \nDeltagelse i Public Evaluation:  http://ec.europa.eu/newsroom/sante/newsletter-specific-archive-issue.cfm?newsletter_service_id=327&newsletter_issue_id=5171&page=1&fullDate=Wed%2020%20Sep%202017&lang=default \nhttps://ec.europa.eu/health/sites/health/files/blood_tissues_organs/docs/ev_20170920_sr_en.pdf \n \nDeltagelse i m\u00f8de med EU-kommissionen:  https://ec.europa.eu/health/sites/health/files/blood_tissues_organs/docs/ev_20171116_ag_en.pdf \n \nDeltagelse i ICF-meeting. \n  \nDeltagelse ESHRE (Juli 2018). \n \nIndbragt sag for Implementeringsr\u00e5det vedr\u00f8rende dansk overimplementering af v\u00e6vsdirektivet, som fejlagtigt g\u00f8r genetisk sygdom hos b\u00f8rn til \u201dalvorlig u\u00f8nsket bivirkning\u201d (Primo 2018).  \n \n \nH\u00f8ringssvar p\u00e5 udkast til bekendtg\u00f8relse om kvalitet og sikkerhed ved h\u00e5ndtering af humane v\u00e6v og celler af 06-07-2018.  \n \nRedeg\u00f8relse til STPS med forslag til indholdsm\u00e6ssige og strukturelle \u00e6ndringer i lov om assisteret reproduktion og v\u00e6vslovgivningen med henblik p\u00e5 at opn\u00e5 en mere sammenh\u00e6ngende, overskuelig og praktisk anvendelig lovgivning, samt en bedre sikring af ensartede konkurrencevilk\u00e5r for v\u00e6vscentre i EU (August 2018) \n \nNotat til Sundhedsministeriet om hensigtsm\u00e6ssigheden af en generel indf\u00f8relse af Cryos\u2019 CON-system og det heriboende vidensdelingsfremmende \u201d\u00e5benheds/tranparensprincip\u201d omkring konstaterede b\u00e6rerstatusser for genetiske sygdomme hos k\u00f8nscelledonorer fremfor det nuv\u00e6rende rapid alert-system, som er baseret p\u00e5 \u201dblokerings-princippet\u201d, der har en h\u00e6mmende effekt p\u00e5 samhandel og \u00e5benhed mellem de involverede stakeholders (September 2018)-", "financial_year_end_date": "01/04/2018", "lat": "56.1583157", "estimate_of_costs_as_a_range": "10000-24999", "overall_budget_turnover_absolute_amount": "0", "legal_status": "ApS", "procurement": "", "customers": "", "belgium_office_post_box": "", "goals__remit": "Vision:  \nTo help childless make their dream come true. \n \nMission: \nTo provide high quality human sperm and eggs from selected and screened donors of all ethnicities and phenotypes. \n \nValues: \nOur values express our beliefs and culture. They outline the foundation for how we work in order to achieve our vision and mission. Furthermore, they define how we operate in relation to our customers, donors, and other interest groups, such as legislators and journalists.  \n \nHelp & Care is to...  \nmake our services easily accessible \nhelp our donors and customers through the decision process \u00a0 \u00a0 \u00a0 \ncare about our donors\u2019 and customers\u2019 needs and wishes \n \nSafety & Professionalism is to...  \nensure high standards of quality and safety \nhave an honest and thorough business approach \nfocus on documented and traceable procedures \n \nInnovation & Development is to...  \nallocate resources for innovation and research \nseek new challenges with an open mind \ncooperate and network internationally \n \nEthics & Responsibility is to...  \nbelieve in the donors\u2019 and customers\u2019 right to choose \nprotect the interests\u00a0of the donors and customers \nanalyse and clarify ethical issues \n \nCryos' goals: \nIt is Cryos' aim to ensure a wide selection of high quality donor sperm from all races and ethnicities. It has always been a hallmark of Cryos to ensure the highest level of service. Furthermore, we will continue to carry and finally maintain and develop our professional knowledge and know-how in the field.\u00a0 \n \nThe Cryos policy is to support scientific research and development related to sperm and male infertility.", "belgium_office_city": "", "head_office_phone": "(+45)86760699"}